Skip to main content
. 2019 Apr 1;6(11):1802332. doi: 10.1002/advs.201802332

Figure 2.

Figure 2

Overview of study design, which was conducted in three stages: a cfBEST proof‐of‐concept experiment, the development of cfBEST using β‐thalassemia as a model, and a blind clinical validation of the cfBEST method.